| Matrix Home Health | |
| 19562 Ventura Blvd, Suite 209, Tarzana, California 91356 | |
| (818) 343-7800 | |
| Name | Matrix Home Health |
|---|---|
| Location | 19562 Ventura Blvd, Suite 209, Tarzana, California |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 59266 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 90002, 90003, 90004, 90008, 90014, 90016, 90024, 90025, 90027, 90028, 90034, 90035, 90036, 90044, 90047, 90048, 90049, 90059, 90064, 90066, 90077, 90210, 90211, 90220, 90230, 90247, 90274, 90275, 90277, 90278, 90302, 90403, 90404, 90405, 90502, 90503, 90505, 90630, 90710, 90712, 90717, 90720, 90731, 90732, 90744, 90745, 90802, 90803, 90805, 90810, 91040, 91202, 91204, 91206, 91302, 91303, 91304, 91306, 91307, 91311, 91316, 91325, 91326, 91331, 91335, 91342, 91343, 91344, 91352, 91356, 91360, 91361, 91364, 91367, 91390, 91401, 91403, 91405, 91406, 91411, 91423, 91436, 91505, 91601, 91602, 91604, 91605, 91606, 91607, 91754, 92683, 93535, 93536 |
| NPI Number | 1831328400 |
| Organization Name | MATRIX HEALTH PROMOTION |
| Doing Business As | MATRIX HOME HEALTH |
| Address | 17141 Ventura Blvd Ste 204, Encino, CA 91316 |
| Phone Number | 818-343-7800 |
News Archive
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, announces the publication of results from an independent, randomised controlled trial of its respiratory disease management tool, Smartinhaler.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag's signing of a major distribution deal.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete contract from the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health, Office of the Surgeon General, Office of the Civilian Volunteer Medical Reserve Corps.
› Verified 3 days ago
| Quality Rating: |
News Archive
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, announces the publication of results from an independent, randomised controlled trial of its respiratory disease management tool, Smartinhaler.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag's signing of a major distribution deal.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete contract from the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health, Office of the Surgeon General, Office of the Civilian Volunteer Medical Reserve Corps.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 91.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 95.6 | 98.6 |
| How often the home health team checked patients’ risk of falling | 98 | 99.6 |
| How often the home health team checked patients for depression | 92 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 83.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 80.1 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.4 | 96.4 |
News Archive
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, announces the publication of results from an independent, randomised controlled trial of its respiratory disease management tool, Smartinhaler.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag's signing of a major distribution deal.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete contract from the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health, Office of the Surgeon General, Office of the Civilian Volunteer Medical Reserve Corps.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 60.5 | 79.6 |
| How often patients got better at getting in and out of bed | 59.9 | 81.1 |
| How often patients got better at bathing | 58.5 | 82.3 |
| How often patients’ breathing improved | 59 | 82.8 |
| How often patients’ wounds improved or healed after an operation | - | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 52.8 | 75 |
| How often home health patients had to be admitted to the hospital | 14.6 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 8.3 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 87.4 | 94 |
News Archive
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, announces the publication of results from an independent, randomised controlled trial of its respiratory disease management tool, Smartinhaler.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag's signing of a major distribution deal.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete contract from the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health, Office of the Surgeon General, Office of the Civilian Volunteer Medical Reserve Corps.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | Not Available |
| Health team communicated well with them | Not Available |
| Health team discussed medicines, pain, and home safety | Not Available |
| How patients rated overall care from agency | Not Available |
News Archive
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, announces the publication of results from an independent, randomised controlled trial of its respiratory disease management tool, Smartinhaler.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag's signing of a major distribution deal.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete contract from the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health, Office of the Surgeon General, Office of the Civilian Volunteer Medical Reserve Corps.
› Verified 3 days ago
The patient survey data of Matrix Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 78 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 70 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 84 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 64 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 71 | 78 |
News Archive
In their paper available on the medRxiv preprint server, researchers from Russia showed that patients with moderate and severe coronavirus disease (COVID-19) have a high incidence of deep vein thrombosis – indicating that they may necessitate an early administration of anticoagulation therapy as a part of their treatment regimen.
Adherium Limited, a global leader in digital health technologies that address sub-optimal medication use in chronic disease, announces the publication of results from an independent, randomised controlled trial of its respiratory disease management tool, Smartinhaler.
QIAGEN N.V. and Celera Corporation today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN's ResPlex II assay for detection of respiratory pathogens.
ITL Virginia Inc, the US subsidiary of medical design and manufacturing company ITL, will be supporting the North American roll-out of the Sentimag system following Endomag's signing of a major distribution deal.
ICF International, a leading provider of consulting services and technology solutions to government and commercial clients, has been awarded a re-compete contract from the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Health, Office of the Surgeon General, Office of the Civilian Volunteer Medical Reserve Corps.
› Verified 3 days ago
Optimal Health Care, Inc Location: 5530 Corbin Ave, #125, Tarzana, California 91356 Ratings: Phone: (818) 609-2663 | |
N & A Home Health Care, Inc Location: 18340 Ventura Boulevard, Suite 209, Tarzana, California 91356 Ratings: NA Phone: (818) 975-6304 | |
Medico Home Health Care, Inc Location: 18455 Burbank Blvd, Suite 205, Tarzana, California 91356 Ratings: NA Phone: (888) 563-0075 | |
Temple Of Life Home Care Location: 18340 Ventura Blvd, Suite 220, Tarzana, California 91356 Ratings: NA Phone: (747) 236-3155 | |
Homeliving Health Providers, Inc Location: 18321 Ventura Blvd, Suite 780, Tarzana, California 91356 Ratings: NA Phone: (818) 609-9000 | |
Valley Home Health Care Agency, Inc Location: 5530 Corbin Avenue, Suite 112, Tarzana, California 91356 Ratings: Phone: (818) 300-0223 |